BMI1 and Alzheimer disease: In conclusion, the findings of our study from two independent well-characterized cohorts provide fundamental evidence that BMI1 and SNPs (rs17415557 and rs72814833) in BMI1 are associated with CSF Aβ1-42, a hallmark biomarker of AD, and cognitive decline rates.